Project

Oceanic AF

Completed - recruitment closed ยท 2023 until 2024

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed - recruitment closed
Start Date
2023
End Date
2024
Financing
Industry
Phase
III
Brief description/objective

A multicenter, international, randomized, active comparator-controlled, double-blind, doubledummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke